Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selegiline Transdermal System for Smoking Cessation
NCT00439413Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Jun 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selegiline transdermal patch in nicotine dependence, sponsored by National Institute on Drug Abuse. Started Jun 2007; status: completed.
02
Drugs
selegiline transdermal patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00439413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439413.